| View |
|
DR-XY27918
|
Levofloxacin (As Hemihydrate)
|
Floxel
|
500 mg/100 mL
|
Solution For IV Infusion
|
-
|
Amherst Parenterals, Inc.
|
Philippines
|
Initial (Variation)
|
23 June 2022
|
30 October 2027
|
| View |
|
DR-XY27919
|
Levofloxacin (As Hemihydrate)
|
Levox
|
5 mg/mL (500 mg/100 mL)
|
Solution For Infusion (Iv)
|
-
|
Amherst Parenterals, Inc.
|
Philippines
|
Initial (Variation)
|
24 June 2022
|
13 November 2027
|
| View |
|
DR-XY27920
|
Pramipexole Dihydrochloride Monohydrate
|
Sifrol
|
1 mg
|
Tablet
|
For The Treatment Of Parkinson'S Disease, And For The Treatment Of Moderate To Severe Restless Legs Syndrome
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Automatic Renewal (E-AR)
|
06 March 2024
|
11 December 2028
|
| View |
|
DR-XY27922
|
Pramipexole Dihydrochloride Monohydrate
|
Sifrol
|
250 mcg
|
Tablet
|
Antiparkinsonism
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Renewal
|
16 November 2023
|
11 December 2028
|
| View |
|
DR-XY27927
|
Cefoxitin Sodium
|
MONOWEL
|
1 g
|
Sterile Powder for Injection
|
Antibacterial (Cephalosporin)
|
Biolab Co., Limited
|
Thailand
|
Renewal
|
25 April 2022
|
09 October 2027
|
| View |
|
DR-XY27928
|
Parecoxib (As Sodium)
|
Dynastat
|
40 mg
|
Lyophilized Powder for IM/IV Injection
|
-
|
Pharmacia & Upjohn Company LLC
|
U.S.A.
|
-
|
10 November 2021
|
25 January 2026
|
| View |
|
DR-XY27931
|
Chlorphenamine Maleate
|
None
|
10mg/mL
|
Solution for Injection (IM/IV/SC)
|
Antihistamine
|
Atlantic Laboratories Corporation Limited
|
Thailand
|
-
|
21 March 2022
|
11 October 2027
|
| View |
|
DR-XY27940
|
Methylphenidate hydrochloride
|
Concerta
|
18 mg
|
Extended-Release Tablet
|
Medicine for Attention Deficit Hyperactivity Disorder (ADHD)
|
Janssen Cilag Manufacturing L.L.C.
|
Puerto Rico
|
Renewal
|
22 August 2022
|
03 August 2027
|
| View |
|
DR-XY27941
|
Methylphenidate Hydrochloride
|
Concerta
|
36 mg
|
Extended-Release Tablet
|
Medicine for Attention Deficit Hyperactivity Disorder (ADHD)
|
Janssen-Cilag Manufacturing L.L.C.
|
Puerto Rico
|
Automatic Renewal
|
01 August 2022
|
03 August 2027
|
| View |
|
DR-XY27945
|
0.5% Bupivacaine Hydrochloride in 8% Dextrose
|
None
|
5 mg/80 mg per mL
|
Solution for Injection (Spinal)
|
-
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
-
|
18 April 2022
|
15 October 2027
|
| View |
|
DR-XY27956
|
Fluticasone Propionate
|
Flixotide
|
50mcg/actuation
|
Metered-Dose Inhaler (Non-Cfc)
|
Drug for Obstructive Airway Diseases (Glucocorticoid)
|
Glaxo Wellcome S.A.
|
Spain
|
Automatic Renewal
|
08 September 2022
|
17 October 2027
|
| View |
|
DR-XY27978
|
Hyoscine Butylbromide
|
Spanil
|
20mg/mL
|
Solution For Injection
|
Anticholinergics
|
T.P. Drug Laboratories (1969) Co., Ltd.
|
Thailand
|
Automatic Renewal
|
31 August 2022
|
23 October 2027
|
| View |
|
DR-XY27979
|
Trace Elements Concentrated Solution
|
Tracutil
|
See package insert
|
Solution For Intravenous Infusion
|
Trace Elements
|
B. Braun Medical AG
|
Switzerland
|
Automatic Renewal
|
12 September 2022
|
23 October 2027
|
| View |
|
DR-XY27981
|
Cefaclor (As Monohdyrate)
|
Zyrcef
|
500 mg
|
Capsule
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal
|
07 October 2022
|
24 October 2027
|
| View |
|
DR-XY27982
|
Pyrazinamide
|
Pyrazuer
|
500 mg
|
Tablet
|
Antituberculosis
|
Flamingo Pharmaceuticals Ltd
|
India
|
Automatic Renewal
|
18 July 2022
|
24 October 2027
|
| View |
|
DR-XY27986
|
Cefaclor (as monohydrate)
|
Clorgen
|
125 mg/5 mL
|
Granules for Suspension
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
22 August 2022
|
25 October 2027
|
| View |
|
DR-XY27996
|
Haloperidol
|
Seredol
|
5mg/mL
|
Solution For Injection (Im)
|
Antipsychotic
|
Atlantic Laboratories Corp. Ltd.
|
Thailand
|
Renewal
|
04 August 2024
|
20 September 2029
|
| View |
|
DR-XY27998
|
Retinol (As Palmitate)
|
None
|
200,000 IU
|
Softgel Capsule
|
Vitamin
|
Interphil Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
28 October 2027
|
| View |
|
DR-XY28007
|
Pyrazinamide
|
Zinaplex
|
500 mg/ 5 mL
|
Suspension
|
Antituberculosis
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
09 January 2023
|
07 January 2028
|
| View |
|
DR-XY28008
|
Levocetirizine Dihydrochloride
|
Xyzal
|
5mg
|
Film-Coated Tablet
|
Antihistamine
|
UCB Farchim S.A.
|
Switzerland
|
Automatic Renewal
|
24 September 2021
|
31 October 2026
|